Our observations are consistent with recent studies that identified the aberrant activation of mTORC1 in GBM and in HCC cellular models as responsible for the up-regulation of NRF2 (Komatsu et al, 2010; Pölönen et al, 2019). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.